In colorectal cancer patients, galectin-1 attenuated cytotoxic CD8+ T-cell-killing activity and showed high expression, especially in stroma cells, which led to poor overall survival in colorectal cancer patients [141]. Here, LGALS1 is linked to colorectal cancer.